Skip to main content
Erschienen in: World Journal of Urology 4/2015

01.04.2015 | Topic Paper

Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement

verfasst von: Iason Kyriazis, Piotr P. Świniarski, Stephan Jutzi, Mathias Wolters, Christopher Netsch, Martin Burchardt, Evangelos Liatsikos, Shujie Xia, Thorsten Bach, Andreas J. Gross, Thomas R. W. Herrmann

Erschienen in: World Journal of Urology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Retrograde transurethral anatomical enucleation of the prostate is gaining momentum as a new concept in transurethral surgery of benign prostatic hyperplasia. Its adaptation is boosted by the familiarity of urologists with the finger-assisted anatomical enucleation of the adenoma during open prostatectomy and the combination of this well-established concept with the minimal invasive characteristics of transurethral surgery. The thulium laser appears as an ideal energy source for such operation. In this work, current evidence on thulium laser-assisted anatomical enucleation of the prostate (ThuLEP) is being reviewed.

Materials and Methods

A comprehensive literature review was performed on Medline, PubMed, and Cochrane databases retrieving all literature on thulium laser-assisted prostatectomy between 2006 and 2015. Experimental studies, review articles and editorial comments as well as studies on thulium laser-assisted approaches other than ThuLEP (i.e., ThuVEP, ThuVAP or ThuVARP) were excluded from the analysis.

Results

In total, six original articles on either surgical technique or clinical outcomes were retrieved. With regard to functional results, ThuLEP presented no significant differences toward the standard treatment (TURP/HoLEP) arm in two randomized controlled trials and favorable outcomes in available prospective cohorts. Observed morbidity was minimum and comparable with the rest of transurethral literature.

Conclusions

ThuLEP literature is still very limited. Based on the available data, the approach is safe and effective, demonstrating favorable outcomes, comparable with the current standard treatment options. Further documentation of ThuLEP outcomes is necessary to define the optimum indications of this novel technique.
Literatur
1.
Zurück zum Zitat Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9(2):151–153CrossRefPubMed Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9(2):151–153CrossRefPubMed
2.
Zurück zum Zitat Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225CrossRefPubMed Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225CrossRefPubMed
3.
Zurück zum Zitat Herrmann TR, Liatsikos EN, Nagele U et al (2012) EAU guidelines on laser technologies. Eur Urol 61(4):783–795CrossRefPubMed Herrmann TR, Liatsikos EN, Nagele U et al (2012) EAU guidelines on laser technologies. Eur Urol 61(4):783–795CrossRefPubMed
4.
Zurück zum Zitat Bach TL, Xia SJ, Yang Y et al (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed Bach TL, Xia SJ, Yang Y et al (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed
5.
Zurück zum Zitat Herrmann TR, Bach T, Imkamp F, Georgiou A et al (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefPubMed Herrmann TR, Bach T, Imkamp F, Georgiou A et al (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefPubMed
6.
Zurück zum Zitat Iacono F, Prezioso D, Di Lauro G et al (2012) Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg 12(Suppl 1):S21CrossRefPubMedCentralPubMed Iacono F, Prezioso D, Di Lauro G et al (2012) Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg 12(Suppl 1):S21CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Rausch S, Heider T, Bedke J et al (2015) Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome. Urology 85(1):182–188CrossRefPubMed Rausch S, Heider T, Bedke J et al (2015) Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome. Urology 85(1):182–188CrossRefPubMed
8.
Zurück zum Zitat Shao Q, Zhang FB, Shang DH, Tian Y (2009) Comparison of holmium and thulium laser in transurethral enucleation of the prostate. Zhonghua Nan Ke Xue 15(4):346–349PubMed Shao Q, Zhang FB, Shang DH, Tian Y (2009) Comparison of holmium and thulium laser in transurethral enucleation of the prostate. Zhonghua Nan Ke Xue 15(4):346–349PubMed
9.
Zurück zum Zitat Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y (2012) Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79(4):869–874CrossRefPubMed Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y (2012) Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79(4):869–874CrossRefPubMed
10.
Zurück zum Zitat Świniarski PP, Stępień S, Dudzic W et al (2012) Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. Cent European J Urol 65(3):130–134CrossRef Świniarski PP, Stępień S, Dudzic W et al (2012) Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. Cent European J Urol 65(3):130–134CrossRef
11.
Zurück zum Zitat Hochreiter WW, Thalmann GN, Burkhard FC et al (2002) Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 168:1470–1474CrossRefPubMed Hochreiter WW, Thalmann GN, Burkhard FC et al (2002) Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 168:1470–1474CrossRefPubMed
12.
Zurück zum Zitat Tinmouth WW, Habib E, Kim SC et al (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19(5):550–554CrossRefPubMed Tinmouth WW, Habib E, Kim SC et al (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19(5):550–554CrossRefPubMed
13.
Zurück zum Zitat Gomez Sancha F, Rivera VC et al (2014) Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol [Epub ahead of print] Gomez Sancha F, Rivera VC et al (2014) Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol [Epub ahead of print]
14.
Zurück zum Zitat Cornu JN, Ahyai S, Bachmann A et al (2014) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. doi:10.1016/j.eururo.2014.06.017 Cornu JN, Ahyai S, Bachmann A et al (2014) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. doi:10.​1016/​j.​eururo.​2014.​06.​017
Metadaten
Titel
Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement
verfasst von
Iason Kyriazis
Piotr P. Świniarski
Stephan Jutzi
Mathias Wolters
Christopher Netsch
Martin Burchardt
Evangelos Liatsikos
Shujie Xia
Thorsten Bach
Andreas J. Gross
Thomas R. W. Herrmann
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1529-0

Weitere Artikel der Ausgabe 4/2015

World Journal of Urology 4/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.